title: Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.
authors: Stephan
authors: S
authors: Rosenkranz
authors: Frank
authors: F
authors: Diet
authors: Thomas
authors: T
authors: Karasch
authors: Julia
authors: J
authors: Weihrauch
authors: Klaus
authors: K
authors: Wassermann
authors: Erland
authors: E
authors: Erdmann
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000368:Aged; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010879:Piperazines / Q000627:therapeutic use*; D011658:Pulmonary Fibrosis / Q000150:complications*; D011687:Purines; D011928:Raynaud Disease / Q000150:complications* / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000150:complications*; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D020097:Natriuretic Peptide, Brain; D000068677:Sildenafil Citrate; D015106:3',5'-Cyclic-GMP Phosphodiesterases